Strategic Asset Sale Genetic Technology Inc. recently divested its geneType business and assets to Rhythm Biosciences, indicating a strategic shift that may open opportunities for partners interested in their core genomics capabilities or related diagnostic technologies.

New Platform Launch The global launch of the geneType(TM) on the EasyDNA platform presents an opportunity to target healthcare providers and biotech firms seeking innovative genomics testing solutions with scalable infrastructure.

Partnership Expansion Recent collaborations with CancerIQ and Wellworks for You Inc. highlight the company’s focus on health and wellness sectors, creating potential channels to sell complementary products or integrated health solutions.

Geographic Growth Expansion of North American offices signals increased capacity and presence in a key market, providing a strategic entry point for sales teams to access the growing North American genomics and health tech sectors.

Leadership Strength The appointment of a globally experienced CFO and the company’s active partnerships suggest a focus on strengthening financial health and strategic positioning, offering confidence for potential partners interested in long-term collaborations and co-marketing efforts.